Platelet-released extracellular vesicles: the effects of thrombin activation.


Journal

Cellular and molecular life sciences : CMLS
ISSN: 1420-9071
Titre abrégé: Cell Mol Life Sci
Pays: Switzerland
ID NLM: 9705402

Informations de publication

Date de publication:
14 Mar 2022
Historique:
received: 08 12 2021
accepted: 23 02 2022
revised: 17 02 2022
entrez: 15 3 2022
pubmed: 16 3 2022
medline: 18 3 2022
Statut: epublish

Résumé

Platelets exert fundamental roles in thrombosis, inflammation, and angiogenesis, contributing to different pathologies from cardiovascular diseases to cancer. We previously reported that platelets release extracellular vesicles (pEVs) which contribute to thrombus formation. However, pEV composition remains poorly defined. Indeed, pEV quality and type, rather than quantity, may be relevant in intravascular cross-talk with either circulating or vascular cells. We aimed to define the phenotypic characteristics of pEVs released spontaneously and those induced by thrombin activation to better understand their role in disease dissemination. pEVs obtained from washed platelets from healthy donor blood were characterized by flow cytometry. pEVs from thrombin-activated platelets (T-pEVs) showed higher levels of P-selectin and active form of glycoprotein IIb/IIIa than baseline non-activated platelets (B-pEVs). Following mass spectrometry-based differential proteomic analysis, significant changes in the abundance of proteins secreted in T-pEVs compared to B-pEVs were found. These differential proteins were involved in coagulation, adhesion, cytoskeleton, signal transduction, metabolism, and vesicle-mediated transport. Interestingly, release of proteins relevant for cell adhesion, intrinsic pathway coagulation, and platelet activation signalling was significantly modified by thrombin stimulation. A novel pEV-associated protein (protocadherin-α4) was found to be significantly reduced in T-pEVs showing a shift towards increased expression in the membranes of activated platelets. In summary, platelet activation induced by thrombin triggers the shedding of pEVs with a complex proteomic pattern rich in procoagulant and proadhesive proteins. Crosstalk with other vascular and blood cells in a paracrine regulatory mode could extend the prothrombotic signalling as well as promote proteostasic changes in other cellular types.

Identifiants

pubmed: 35288766
doi: 10.1007/s00018-022-04222-4
pii: 10.1007/s00018-022-04222-4
pmc: PMC8920058
doi:

Substances chimiques

Proteins 0
Thrombin EC 3.4.21.5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

190

Subventions

Organisme : National Plan for Science and Innovation
ID : PID2019-107160RB-I00
Organisme : National Plan for Science and Innovation
ID : PGC2018-094025-B-I00
Organisme : Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares
ID : CB16/11/00411
Organisme : Instituto de Salud Carlos III
ID : FIS PI19/01687
Organisme : Departament d'Universitats, Recerca i Societat de la Informació
ID : 2017 SGR 1480
Organisme : Agència de Gestió d'Ajuts Universitaris i de Recerca
ID : 2019BP00211

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Références

Methods Mol Biol. 2015;1318:87-96
pubmed: 26160567
Proteomics. 2015 Aug;15(15):2597-601
pubmed: 25921073
Cardiovasc Res. 2014 Jul 1;103(1):140-6
pubmed: 24776597
Br J Haematol. 1999 Mar;104(3):448-54
pubmed: 10086777
Oncogene. 2012 Feb 2;31(5):653-63
pubmed: 21725358
PLoS One. 2020 Aug 19;15(8):e0236439
pubmed: 32813744
Proc Natl Acad Sci U S A. 2009 Nov 24;106(47):19836-41
pubmed: 19901330
J Biol Chem. 2010 Apr 9;285(15):11402-10
pubmed: 20164183
Blood Coagul Fibrinolysis. 2009 Jan;20(1):63-70
pubmed: 20523167
Thromb Haemost. 2015 Nov 25;114(6):1310-21
pubmed: 26178021
J Cell Sci. 2018 Nov 30;131(23):
pubmed: 30404830
Blood. 2002 Aug 1;100(3):897-904
pubmed: 12130500
Anal Chim Acta. 2013 May 7;776:57-63
pubmed: 23601281
Blood Adv. 2020 Jul 14;4(13):3011-3023
pubmed: 32614966
Front Pharmacol. 2016 Aug 31;7:293
pubmed: 27630570
Thromb Haemost. 2013 Aug;110(2):366-77
pubmed: 23740299
J Proteome Res. 2005 Sep-Oct;4(5):1516-21
pubmed: 16212402
J Clin Invest. 2008 Mar;118(3):1123-31
pubmed: 18292814
Blood Rev. 2007 May;21(3):157-71
pubmed: 17118501
J Thromb Haemost. 2012 Feb;10(2):278-88
pubmed: 22168334
Nat Med. 2009 Mar;15(3):306-12
pubmed: 19234463
J Proteomics. 2012 Jun 27;75(12):3574-84
pubmed: 22516433
Thromb Haemost. 2001 Apr;85(4):639-46
pubmed: 11341498
Sci Signal. 2008 Feb 26;1(8):pe10
pubmed: 18314504
Thromb Haemost. 2007 Apr;97(4):650-7
pubmed: 17393029
Semin Thromb Hemost. 2010 Nov;36(8):845-56
pubmed: 21049385
PLoS Biol. 2012;10(12):e1001450
pubmed: 23271954
Sci Rep. 2018 Jul 3;8(1):9987
pubmed: 29968812
JACC Basic Transl Sci. 2021 Mar;6(3):202-218
pubmed: 33649738
Thromb Haemost. 2012 Dec;108(6):1208-19
pubmed: 23138460
J Proteome Res. 2012 Apr 6;11(4):2154-63
pubmed: 22329422
Elife. 2018 Jun 18;7:
pubmed: 29911975
Thromb Haemost. 2001 Jul;86(1):356-65
pubmed: 11487025
Nat Med. 2008 Mar;14(3):325-30
pubmed: 18278053
J Proteomics. 2009 Feb 15;72(1):91-109
pubmed: 19049909
Sci Rep. 2015 Feb 03;5:8198
pubmed: 25645904
Proteomics. 2019 Jan;19(1-2):e1800247
pubmed: 30467982
Thromb Haemost. 2011 May;105 Suppl 1:S34-42
pubmed: 21479344
Nat Biotechnol. 2007 Aug;25(8):887-93
pubmed: 17687369
Circ Res. 2010 Oct 29;107(9):1047-57
pubmed: 21030722
Thromb Haemost. 2014 Jan;111(1):111-21
pubmed: 24085382
J Am Coll Cardiol. 1994 Jun;23(7):1562-9
pubmed: 8195515
J Proteomics. 2012 Dec 5;76 Spec No.:287-96
pubmed: 22415276
Nature. 2002 Jun 6;417(6889):664-7
pubmed: 12050670
Thromb Haemost. 2007 Jan;97(1):67-80
pubmed: 17200773
J Thromb Haemost. 2013 Nov;11(11):2048-58
pubmed: 24119011
Semin Thromb Hemost. 2010 Nov;36(8):881-7
pubmed: 21049389
Arterioscler Thromb Vasc Biol. 2021 Jan;41(1):87-96
pubmed: 33028092
J Proteomics. 2015 May 21;121:56-66
pubmed: 25835965
Nature. 2000 Sep 14;407(6801):258-64
pubmed: 11001069
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2560-9
pubmed: 21836071
J Biol Chem. 2009 Jan 30;284(5):2880-2890
pubmed: 19047047
J Extracell Vesicles. 2018 Nov 23;7(1):1535750
pubmed: 30637094
Int J Cardiol. 2013 Oct 15;168(6):5196-204
pubmed: 23992930
Arterioscler Thromb Vasc Biol. 2021 Mar;41(3):999-1011
pubmed: 33441027
Biochimie. 2010 Nov;92(11):1568-79
pubmed: 20346387
Thromb Res. 2012 Jul;130(1):122-8
pubmed: 22014850
Am Heart J. 1995 Feb;129(2):234-8
pubmed: 7832094
Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):255-6
pubmed: 17185627
J Extracell Vesicles. 2021 Sep;10(11):e12140
pubmed: 34520123
Curr Opin Hematol. 2015 Sep;22(5):437-44
pubmed: 26214207
Blood. 2007 Nov 15;110(10):3637-47
pubmed: 17664349
J Mol Biol. 2016 Feb 22;428(4):688-692
pubmed: 26434508
Exp Cell Res. 2004 Apr 1;294(2):494-508
pubmed: 15023537
Atherosclerosis. 2015 Sep;242(1):145-54
pubmed: 26188538
Arterioscler Thromb Vasc Biol. 2010 Jun;30(6):1246-52
pubmed: 20360535
Thromb Haemost. 2009 Oct;102(4):711-8
pubmed: 19806257
Arterioscler Thromb Vasc Biol. 2019 Jun;39(6):1172-1181
pubmed: 31070479

Auteurs

Rosa Suades (R)

Cardiovascular Program ICCC, Research Institute Hospital Santa Creu i Sant Pau, IIB Sant Pau, c/Sant Antoni Mª Claret 167, 08025, Barcelona, Spain.

Teresa Padró (T)

Cardiovascular Program ICCC, Research Institute Hospital Santa Creu i Sant Pau, IIB Sant Pau, c/Sant Antoni Mª Claret 167, 08025, Barcelona, Spain.
CIBERCV Instituto de Salud Carlos III, Madrid, Spain.

Gemma Vilahur (G)

Cardiovascular Program ICCC, Research Institute Hospital Santa Creu i Sant Pau, IIB Sant Pau, c/Sant Antoni Mª Claret 167, 08025, Barcelona, Spain.
CIBERCV Instituto de Salud Carlos III, Madrid, Spain.

Lina Badimon (L)

Cardiovascular Program ICCC, Research Institute Hospital Santa Creu i Sant Pau, IIB Sant Pau, c/Sant Antoni Mª Claret 167, 08025, Barcelona, Spain. LBadimon@santpau.cat.
CIBERCV Instituto de Salud Carlos III, Madrid, Spain. LBadimon@santpau.cat.
Cardiovascular Research Chair, UAB, Barcelona, Spain. LBadimon@santpau.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH